Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference TrendingStockAlerts · Mar 22, 2025
Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal Trials with Accelerating Multi-market Revenue Ramp Up TrendingStockAlerts · Mar 21, 2025
Multiple Myeloma Market to Witness Substantial Growth -- Key Trends and Forecasts of Different Reports for the Next Decade | DelveInsight TrendingStockAlerts · Mar 20, 2025
Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics TrendingStockAlerts · Mar 18, 2025
Skyhawk Therapeutics Presents at Huntington's Disease Youth Organization HDYO International Congress 2025 TrendingStockAlerts · Mar 17, 2025
iOncologi, Inc. Acquires TargImmune Therapeutics to Expand and Strengthen Immunotherapy Pipeline Against Solid Tumors TrendingStockAlerts · Mar 16, 2025
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors TrendingStockAlerts · Mar 14, 2025
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership TrendingStockAlerts · Mar 13, 2025
